BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib.

BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib. Haematologica. 2017 Oct 05;: Authors: Byrgazov K, Lucini CB, Valent P, Hantschel O, Lion T PMID: 28983061 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28983061?dopt=Abstract

Source: Haematologica - October 5, 2017 Category: Hematology Authors: Byrgazov K, Lucini CB, Valent P, Hantschel O, Lion T Tags: Haematologica Source Type: research

More News: Hematology